UY23929A1 - Procedimiento de preparacion de derivados del indol - Google Patents
Procedimiento de preparacion de derivados del indolInfo
- Publication number
- UY23929A1 UY23929A1 UY23929A UY23929A UY23929A1 UY 23929 A1 UY23929 A1 UY 23929A1 UY 23929 A UY23929 A UY 23929A UY 23929 A UY23929 A UY 23929A UY 23929 A1 UY23929 A1 UY 23929A1
- Authority
- UY
- Uruguay
- Prior art keywords
- indole
- preparation
- derivatives
- aminoethyl
- boron hydride
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9400481A ES2084560B1 (es) | 1994-03-09 | 1994-03-09 | Procedimiento de preparacion de derivados el indol. |
Publications (1)
Publication Number | Publication Date |
---|---|
UY23929A1 true UY23929A1 (es) | 1995-03-21 |
Family
ID=8285486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY23929A UY23929A1 (es) | 1994-03-09 | 1995-03-09 | Procedimiento de preparacion de derivados del indol |
Country Status (6)
Country | Link |
---|---|
BR (1) | BR9500821A (fi) |
CO (1) | CO4340738A1 (fi) |
EG (1) | EG20611A (fi) |
ES (1) | ES2084560B1 (fi) |
FI (1) | FI116837B (fi) |
UY (1) | UY23929A1 (fi) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007013098A1 (en) * | 2005-07-25 | 2007-02-01 | Matrix Laboratories Limited | A process for the preparation of almotriptan |
ES2505715T1 (es) | 2013-02-06 | 2014-10-10 | Galenicum Health S.L. | Composición farmacéutica que comprende almotriptán malato que tiene una distribución y potencia uniforme |
CN106478484B (zh) * | 2016-08-31 | 2017-11-10 | 重庆华森制药股份有限公司 | 一种制备阿莫曲坦关键中间体的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1171449B (it) * | 1980-08-12 | 1987-06-10 | Glaxo Group Ltd | Composti eterociclici indolici procedimento per produrli e composizioni farmaceutiche che li contengono |
GB8332437D0 (en) * | 1983-12-06 | 1984-01-11 | Glaxo Group Ltd | Chemical compounds |
GB8419575D0 (en) * | 1984-08-01 | 1984-09-05 | Glaxo Group Ltd | Chemical compounds |
ES2033577B1 (es) * | 1991-06-06 | 1995-01-16 | Quimica Sint S A Con El 50 | Procedimiento para la obtencion de la 2-carboxi-3-(2-(dimetilamino)etil)-n-metil-1h-indol-5-metanosulfonamida y sus esteres alquilicos inferiores. |
ES2033578B1 (es) * | 1991-06-06 | 1995-01-16 | Quimica Sint S A Con El 50 | Procedimiento para la obtencion de 3-(2-(dimetilamino)etil)-n-metil-1h-indol-5-metanosulfonamida. |
-
1994
- 1994-03-09 ES ES9400481A patent/ES2084560B1/es not_active Expired - Fee Related
-
1995
- 1995-03-06 BR BR9500821A patent/BR9500821A/pt not_active Application Discontinuation
- 1995-03-07 FI FI951047A patent/FI116837B/fi not_active IP Right Cessation
- 1995-03-07 CO CO95008919A patent/CO4340738A1/es unknown
- 1995-03-08 EG EG17595A patent/EG20611A/xx active
- 1995-03-09 UY UY23929A patent/UY23929A1/es not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI951047A0 (fi) | 1995-03-07 |
FI116837B (fi) | 2006-03-15 |
CO4340738A1 (es) | 1996-07-30 |
BR9500821A (pt) | 1995-11-21 |
ES2084560A1 (es) | 1996-05-01 |
ES2084560B1 (es) | 1997-01-16 |
FI951047A (fi) | 1995-09-10 |
EG20611A (en) | 1999-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100545435B1 (ko) | 인돌린 유도체 및 5-ht2 수용체 리간드로서의 이들의 용도 | |
RU2382031C2 (ru) | 3-амино-1-арилпропилиндолы, применяемые в качестве ингибиторов обратного захвата моноаминов | |
IE58122B1 (en) | An indole derivative | |
US20040143003A1 (en) | Cyclopropylindole derivatives as selective serotonin reuptake inhibitors | |
IL176111A (en) | Derivatives 2– (H1– indulisulphenyl) –benzyl amine as SSRI | |
JPH09508137A (ja) | セロトニンアゴニストおよびアンタゴニストとしての4−インドール誘導体 | |
KR100361950B1 (ko) | 3-인돌릴피페리딘 | |
MEP45408A (en) | 6-position substituted indoline, production and use thereof as a medicament | |
IE55358B1 (en) | Indoles | |
NL8403719A (nl) | Chemische verbindingen. | |
EP1771415B1 (en) | 2- (1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence | |
Robinson | Reduction of indoles and related compounds | |
RU2132683C1 (ru) | Применение производных индола в качестве 5hti агонистов | |
EA200300266A1 (ru) | Новые сложные эфиры апорфина и их применение в терапии | |
NZ197998A (en) | 5-amino(methyl)-1h-indol-3-ylalkaneamines | |
IL97426A (en) | Pharmaceutical preparations, for the use of intraocular pressure in glaucoma, containing metamorphic indoles, and some new compounds from the left | |
JPH08504786A (ja) | 5−ht▲下1▼様アゴニスト用トリプタミンアナログ | |
UY23929A1 (es) | Procedimiento de preparacion de derivados del indol | |
EP1331935B1 (en) | Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them | |
Bishop et al. | New 5-HT2C receptor agonists | |
Macor et al. | 5-[(3-Nitropyrid-2-yl) amino] indoles: Novel serotonin agonists with selectivity for the 5-HT1D receptor. Variation of the C3 substituent on the indole template leads to increased 5-HT1D receptor selectivity | |
NO321697B1 (no) | Indol derivater | |
JPH04505923A (ja) | インデノインドール化合物2 | |
US7618967B2 (en) | Indane compounds | |
Benington et al. | Synthesis of O-and N-methylated derivatives of 5-hydroxytryptamine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
VENC | Patent expired |
Effective date: 20141115 |